1200 participants
Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2008-12-08
- Start Date:
- 2002-10-31
- Completion:
- 2003-03-31
Conditions
- Influenza
Interventions
- BIOLOGICAL
No Results Yet